triamcinolone

(redirected from Nasacort aq)
Also found in: Dictionary, Thesaurus, Encyclopedia.

triamcinolone

 [tri″am-sin´o-lōn]
a prednisolone derivative used in replacement therapy for adrenocortical insufficiency and as an antiinflammatory and immunosuppressant in a wide variety of disorders; administered orally in the form of the acetonide, diacetate, and hexacetonide esters.

triamcinolone

/tri·am·cin·o·lone/ (tri″am-sin´o-lōn) a synthetic glucocorticoid used in replacement therapy for adrenocortical insufficiency and as an antiinflammatory and immunosuppressant in a wide variety of disorders.

triamcinolone

(trī′ăm-sĭn′ə-lōn′)
n.
A synthetic glucocorticoid, C21H27FO6, used, usually in acetal or acetate forms, in the treatment of a wide variety of inflammatory and allergic conditions.

triamcinolone

[trī′amsin′əlōn]
a corticosteroid.
indications It is prescribed topically as an antiinflammatory agent in the treatment of dermatoses, stomatitis, and lichen planus lesions, is inhaled for the treatment of allergies and asthma, is injected (e.g., into joints) for the treatment of local inflammation, and is taken orally in low doses for treatment of adrenocortical insufficiency and in higher antiinflammatory/immunosuppressive doses for the treatment of systemic diseases such as systemic lupus erythematosus.
contraindications Fungal infections or known hypersensitivity to this drug prohibits its systemic use. Viral or fungal infections of the skin, impaired circulation, or known hypersensitivity to this drug prohibits its topical use.
adverse effects Among the more serious adverse effects to the systemic administration of the drug are GI, endocrine, neurological, fluid, and electrolyte disturbances. Skin reactions may occur from topical administration of this drug.

triamcinolone

A CORTICOSTEROID drug used to treat inflammatory disorders, ASTHMA, THROMBOCYTOPENIA and some forms of LEUKAEMIA. Brand names are Adcortyl, Adcortyl in Orabase, Kenalog, Lederspan and Nasacort. Triamcinolone is also an ingredient is a range of preparations for external use.

antiinflammatory drug 

A drug which inhibits or suppresses most inflammatory responses of an allergic, bacterial, traumatic or anaphylactic origin, as well as being immunosuppressant. They include the corticosteroids (e.g. betamethasone, dexamethasone, fluorometholone, hydrocortisone acetate, loteprednol etabonate, prednisolone, rimexolone, triamcinolone). They are sometimes combined with an antibiotic drug (e.g. betamethasone combined with neomycin or sulfacetamide, dexamethasone combined with neomycin or polymyxin B). Corticosteroids have side effects, such as enhancing the activity of herpes simplex virus, fungal overgrowth, raising intraocular pressure or cataract formation.There are other antiinflammatory drugs that are non-steroidal (NSAID) and have little toxicity. They act mainly by blocking prostaglandin synthesis. These include diclofenac sodium, flurbiprofen sodium, indomethacin, ketorolac, nepafenac and oxyphenbutazone. See immunosuppressants; steroid.

chalazion 

A chronic inflammatory lipogranuloma due to retention of the secretion (such as blocked ducts) of a meibomian gland in the tarsus of an eyelid. It is characterized by a gradual painless swelling of the gland without marked inflammatory signs and sometimes astigmatism which is induced by the cyst pressing on the cornea (Fig. C5). Small chalazia may disappear spontaneously but large ones usually have to be incised and curetted (i.e. removal of the pus with a scraper) through a tarsal incision. Resolution may also occur after local injection of a corticosteroid drug (e.g. dexamethasone or triamcinolone). Syn. meibomian cyst (although it is not a true cyst because its walls are made of granulomatous tissue and not lined with epithelium). See internal hordeolum.
Fig. C5 Upper eyelid chalazionenlarge picture
Fig. C5 Upper eyelid chalazion

triamcinolone (trī´amsin´əlōn´),

n a synthetic adrenocorticosteroid that has a potent antiinflammatory effect and is used topically in the treatment of angular cheilosis.

triamcinolone

a prednisolone derivative used as an anti-inflammatory glucocorticoid in the form of the acetonide derivative and the diacetate ester.
References in periodicals archive ?
Among prescription and OTC allergy products, Nasacort AQ and other nasal sprays in the same medication class are considered the most effective treatment for hay fever and other upper respiratory allergies.
The NDAC panel's recommendation will be considered by the FDA in its review of the Supplemental New Drug Application (sNDA) for Nasacort AQ as an OTC treatment.
NASACORT AQ (Triamcinolone Acetonide) Nasal Spray is indicated for the treatment of the nasal symptoms of seasonal and perennial allergic rhinitis in adults and children 6 years of age and older.
The study showed that Nasacort AQ, given as 1 spray/nostril once daily for four weeks to children aged 2-5 years, with year-round allergic rhinitis diagnosed for at least one year, significantly improved the combined symptoms of sneezing, itching, runny nose and congestion, compared with placebo.
The trial included a four-week, multicenter, double-blind treatment period during which 433 children were randomized to receive either Nasacort AQ 110 micrograms or placebo as 1 spray per nostril once daily.
10 /PRNewswire-FirstCall/ -- Data presented at the American College of Allergy, Asthma & Immunology (ACAAI) annual meeting suggests that the intranasal corticosteroid Nasacort AQ (triamcinolone acetonide) Nasal Spray may be used safely and effectively to treat children aged 2-5 years old with year-round allergic rhinitis.
Additionally, in a survey of 9,337 patients who tried Nasacort AQ, nine out of ten said they would ask for it again.
Additionally, in a survey of 9,337 patients who tried Nasacort AQ (triamcinolone acetonide), nine out of ten said they would ask for it again.
One of the benefits of Nasacort AQ is its aqueous formulation, which offers a thixotropic formulation, according to Dr.
new products such as Taxotere, Rilutek, Nasacort AQ and Granocyte added
Indicated for adults and children over age 12, Nasacort AQ will be available in pharmacies nationwide in July.
NEW ORLEANS, March 19 /PRNewswire/ -- A new investigational once-daily water-based nasal spray, Nasacort AQ (triamcinolone acetonide), can safely and effectively treat hay fever symptoms in patients as young as six years of age, according to the results of a new study presented today at the 52nd Annual Meeting of the American Academy of Allergy, Asthma, and Immunology.